Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2018

Open Access 01-12-2018 | Research

Stress-inducible Protein-1 promotes metastasis of gastric cancer via Wnt/β-catenin signaling pathway

Authors: Linlin Huang, Ertao Zhai, Shirong Cai, Yi Lin, Junbin Liao, Huilin Jin, Sui Peng, Lixia Xu, Minhu Chen, Zhirong Zeng

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2018

Login to get access

Abstract

Background

Stress-Inducible Protein-1 (STIP1) is a co-chaperone that associates directly with heat shock proteins, and regulates motility of various types of cancer. In the present study, we investigated the role of STIP1 on metastasis of gastric cancer (GC).

Methods

In vivo metastatic experimental model was employed to investigate the effect of STIP1 on metastasis of GC cells. Loss-of-function and gain-of-function experiments were performed to examine the role of STIP1 on metastasis of GC cells. Western blot, immunofluorescence staining, migration and invasion assays, microarray and KEGG pathway analysis were applied to explore the underlying mechanism.

Results

In current study, we demonstrated that STIP1 promoted lung metastasis of GC cells in vivo. Furthermore, STIP1 significantly enhanced migration and invasion abilities of GC cells. In contrast, knock-down of STIP1 yielded the opposite effects on these phenotypes in vitro. STIP1 promoted tumor metastasis through inducing epithelial-to-mesenchymal transition in GC cells. Mechanistically, STIP1 promoted GC metastasis via up-regulation of targeted genes in Wnt/β-catenin signaling pathway, including c-Myc and Cyclin D1, and accompanied with nuclear translocation of β-catenin.

Conclusions

Our findings indicate that elevated expression of STIP1 exhibited a metastasis-promoting effect in GC cells through activation of Wnt/β-catenin signaling pathway. STIP1 may be served as a potential therapeutic target for preventing GC metastasis.
Appendix
Available only for authorised users
Literature
2.
go back to reference Jiang C, Chen X, Alattar M, Wei J, Liu H. MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer. Cancer Gene Ther. 2015;22:291–301.CrossRefPubMed Jiang C, Chen X, Alattar M, Wei J, Liu H. MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer. Cancer Gene Ther. 2015;22:291–301.CrossRefPubMed
3.
go back to reference Robertson-Tessi M, Gillies RJ, Gatenby RA, Anderson AR. Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes. Cancer Res. 2015;75:1567–79.CrossRefPubMedPubMedCentral Robertson-Tessi M, Gillies RJ, Gatenby RA, Anderson AR. Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes. Cancer Res. 2015;75:1567–79.CrossRefPubMedPubMedCentral
4.
go back to reference Zhao J, Liu Y, Huang G, Cui P, Zhang W, Long ZY. Non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translation. Am J Cancer Res. 2015;5:907–27.PubMedPubMedCentral Zhao J, Liu Y, Huang G, Cui P, Zhang W, Long ZY. Non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translation. Am J Cancer Res. 2015;5:907–27.PubMedPubMedCentral
5.
go back to reference Shim HJ, Kim KR, Hwang JE, Bae WK, Ryu SY, Park YK, et al. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer. Cancer Chemother Pharmacol. 2016;77:605–12.CrossRefPubMed Shim HJ, Kim KR, Hwang JE, Bae WK, Ryu SY, Park YK, et al. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer. Cancer Chemother Pharmacol. 2016;77:605–12.CrossRefPubMed
6.
go back to reference Chambers AF, Groom AC, IC MD. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2:563–72.CrossRefPubMed Chambers AF, Groom AC, IC MD. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2:563–72.CrossRefPubMed
7.
go back to reference Crissman JD. Tumor-host interactions as prognostic factors in the histologic assessment of carcinomas. Pathol Annu. 1986;21(Pt 1):29–52.PubMed Crissman JD. Tumor-host interactions as prognostic factors in the histologic assessment of carcinomas. Pathol Annu. 1986;21(Pt 1):29–52.PubMed
8.
go back to reference Salvesen HB, Haldorsen IS, Trovik J. Markers for individualised therapy in endometrial carcinoma. LANCET ONCOL. 2012;13:e353–61.CrossRefPubMed Salvesen HB, Haldorsen IS, Trovik J. Markers for individualised therapy in endometrial carcinoma. LANCET ONCOL. 2012;13:e353–61.CrossRefPubMed
9.
go back to reference Wik E, Raeder MB, Krakstad C, Trovik J, Birkeland E, Hoivik EA, et al. Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. Clin Cancer Res. 2013;19:1094–105.CrossRefPubMed Wik E, Raeder MB, Krakstad C, Trovik J, Birkeland E, Hoivik EA, et al. Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. Clin Cancer Res. 2013;19:1094–105.CrossRefPubMed
10.
go back to reference Li Y, Xie Y, Cui D, Ma Y, Sui L, Zhu C, et al. Osteopontin promotes invasion, migration and epithelial-mesenchymal transition of human endometrial carcinoma cell HEC-1A through AKT and ERK1/2 signaling. Cell Physiol Biochem. 2015;37:1503–12.CrossRefPubMed Li Y, Xie Y, Cui D, Ma Y, Sui L, Zhu C, et al. Osteopontin promotes invasion, migration and epithelial-mesenchymal transition of human endometrial carcinoma cell HEC-1A through AKT and ERK1/2 signaling. Cell Physiol Biochem. 2015;37:1503–12.CrossRefPubMed
11.
go back to reference Odunuga OO, Longshaw VM, Blatch GL. Hop: more than an Hsp70/Hsp90 adaptor protein. BioEssays. 2004;26:1058–68.CrossRefPubMed Odunuga OO, Longshaw VM, Blatch GL. Hop: more than an Hsp70/Hsp90 adaptor protein. BioEssays. 2004;26:1058–68.CrossRefPubMed
12.
go back to reference Lassle M, Blatch GL, Kundra V, Takatori T, Zetter BR. Stress-inducible, murine protein mSTI1. Characterization of binding domains for heat shock proteins and in vitro phosphorylation by different kinases J BIOL CHEM. 1997;272:1876–84.PubMed Lassle M, Blatch GL, Kundra V, Takatori T, Zetter BR. Stress-inducible, murine protein mSTI1. Characterization of binding domains for heat shock proteins and in vitro phosphorylation by different kinases J BIOL CHEM. 1997;272:1876–84.PubMed
13.
go back to reference Tsai CL, Tsai CN, Lin CY, Chen HW, Lee YS, Chao A, et al. Secreted stress-induced phosphoprotein 1 activates the ALK2-SMAD signaling pathways and promotes cell proliferation of ovarian cancer cells. Cell Rep. 2012;2:283–93.CrossRefPubMed Tsai CL, Tsai CN, Lin CY, Chen HW, Lee YS, Chao A, et al. Secreted stress-induced phosphoprotein 1 activates the ALK2-SMAD signaling pathways and promotes cell proliferation of ovarian cancer cells. Cell Rep. 2012;2:283–93.CrossRefPubMed
14.
go back to reference Li J, Sun X, Wang Z, Chen L, Li D, Zhou J, et al. Regulation of vascular endothelial cell polarization and migration by Hsp70/Hsp90-organizing protein. PLoS One. 2012;7:e36389.CrossRefPubMedPubMedCentral Li J, Sun X, Wang Z, Chen L, Li D, Zhou J, et al. Regulation of vascular endothelial cell polarization and migration by Hsp70/Hsp90-organizing protein. PLoS One. 2012;7:e36389.CrossRefPubMedPubMedCentral
15.
go back to reference Chen Z, Xu L, Su T, Ke Z, Peng Z, Zhang N, et al. Autocrine STIP1 signaling promotes tumor growth and is associated with disease outcome in hepatocellular carcinoma. Biochem Biophys Res Commun. 2017;493:365–72.CrossRefPubMed Chen Z, Xu L, Su T, Ke Z, Peng Z, Zhang N, et al. Autocrine STIP1 signaling promotes tumor growth and is associated with disease outcome in hepatocellular carcinoma. Biochem Biophys Res Commun. 2017;493:365–72.CrossRefPubMed
16.
go back to reference de Souza LE, Moura CM, Bilek ES, Lopes MH, Martins VR, Puschel AW, et al. STI1 antagonizes cytoskeleton collapse mediated by small GTPase Rnd1 and regulates neurite growth. Exp Cell Res. 2014;324:84–91.CrossRefPubMed de Souza LE, Moura CM, Bilek ES, Lopes MH, Martins VR, Puschel AW, et al. STI1 antagonizes cytoskeleton collapse mediated by small GTPase Rnd1 and regulates neurite growth. Exp Cell Res. 2014;324:84–91.CrossRefPubMed
18.
go back to reference Gerami P, Jewell SS, Pouryazdanparast P, Wayne JD, Haghighat Z, Busam KJ, et al. Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma. J MOL DIAGN. 2011;13:352–8.CrossRefPubMedPubMedCentral Gerami P, Jewell SS, Pouryazdanparast P, Wayne JD, Haghighat Z, Busam KJ, et al. Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma. J MOL DIAGN. 2011;13:352–8.CrossRefPubMedPubMedCentral
19.
go back to reference van Kempen PM, Noorlag R, Braunius WW, Moelans CB, Rifi W, Savola S, et al. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma. Cancer Med. 2015;4:1525–35.CrossRefPubMedPubMedCentral van Kempen PM, Noorlag R, Braunius WW, Moelans CB, Rifi W, Savola S, et al. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma. Cancer Med. 2015;4:1525–35.CrossRefPubMedPubMedCentral
20.
go back to reference Sapkota Y, Ghosh S, Lai R, Coe BP, Cass CE, Yasui Y, et al. Germline DNA copy number aberrations identified as potential prognostic factors for breast cancer recurrence. PLoS One. 2013;8:e53850.CrossRefPubMedPubMedCentral Sapkota Y, Ghosh S, Lai R, Coe BP, Cass CE, Yasui Y, et al. Germline DNA copy number aberrations identified as potential prognostic factors for breast cancer recurrence. PLoS One. 2013;8:e53850.CrossRefPubMedPubMedCentral
21.
go back to reference Sun W, Xing B, Sun Y, Du X, Lu M, Hao C, et al. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol Cell Proteomics. 2007;6:1798–808.CrossRefPubMed Sun W, Xing B, Sun Y, Du X, Lu M, Hao C, et al. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol Cell Proteomics. 2007;6:1798–808.CrossRefPubMed
22.
go back to reference Walsh N, O'Donovan N, Kennedy S, Henry M, Meleady P, Clynes M, et al. Identification of pancreatic cancer invasion-related proteins by proteomic analysis. Proteome Sci. 2009;7:3.CrossRefPubMedPubMedCentral Walsh N, O'Donovan N, Kennedy S, Henry M, Meleady P, Clynes M, et al. Identification of pancreatic cancer invasion-related proteins by proteomic analysis. Proteome Sci. 2009;7:3.CrossRefPubMedPubMedCentral
23.
go back to reference Chao A, Lai CH, Tsai CL, Hsueh S, Hsueh C, Lin CY, et al. Tumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancer. PLoS One. 2013;8:e57084.CrossRefPubMedPubMedCentral Chao A, Lai CH, Tsai CL, Hsueh S, Hsueh C, Lin CY, et al. Tumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancer. PLoS One. 2013;8:e57084.CrossRefPubMedPubMedCentral
24.
go back to reference Wang TH, Chao A, Tsai CL, Chang CL, Chen SH, Lee YS, et al. Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. Mol Cell Proteomics. 2010;9:1873–84.CrossRefPubMedPubMedCentral Wang TH, Chao A, Tsai CL, Chang CL, Chen SH, Lee YS, et al. Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. Mol Cell Proteomics. 2010;9:1873–84.CrossRefPubMedPubMedCentral
25.
go back to reference Kubota H, Yamamoto S, Itoh E, Abe Y, Nakamura A, Izumi Y, et al. Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma. Cell Stress Chaperones. 2010;15:1003–11.CrossRefPubMedPubMedCentral Kubota H, Yamamoto S, Itoh E, Abe Y, Nakamura A, Izumi Y, et al. Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma. Cell Stress Chaperones. 2010;15:1003–11.CrossRefPubMedPubMedCentral
26.
go back to reference Padden J, Megger DA, Bracht T, Reis H, Ahrens M, Kohl M, et al. Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma. Mol Cell Proteomics. 2014;13:2661–72.CrossRefPubMedPubMedCentral Padden J, Megger DA, Bracht T, Reis H, Ahrens M, Kohl M, et al. Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma. Mol Cell Proteomics. 2014;13:2661–72.CrossRefPubMedPubMedCentral
27.
go back to reference Willmer T, Contu L, Blatch GL, Edkins AL. Knockdown of hop downregulates RhoC expression, and decreases pseudopodia formation and migration in cancer cell lines. Cancer Lett. 2013;328:252–60.CrossRefPubMed Willmer T, Contu L, Blatch GL, Edkins AL. Knockdown of hop downregulates RhoC expression, and decreases pseudopodia formation and migration in cancer cell lines. Cancer Lett. 2013;328:252–60.CrossRefPubMed
28.
go back to reference Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci. 2006;11:1696–701.CrossRefPubMed Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci. 2006;11:1696–701.CrossRefPubMed
31.
go back to reference Wang QM, Fiol CJ, AA DP-r, Roach PJ. Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J Biol Chem. 1994;269:14566–74.PubMed Wang QM, Fiol CJ, AA DP-r, Roach PJ. Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J Biol Chem. 1994;269:14566–74.PubMed
32.
go back to reference Medina M, Wandosell F. Deconstructing GSK-3: the fine regulation of its activity. Int J Alzheimers Dis. 2011;2011(479249) Medina M, Wandosell F. Deconstructing GSK-3: the fine regulation of its activity. Int J Alzheimers Dis. 2011;2011(479249)
33.
go back to reference Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science. 1996;272:1023–6.CrossRefPubMed Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science. 1996;272:1023–6.CrossRefPubMed
34.
go back to reference Taurin S, Sandbo N, Qin Y, Browning D, Dulin NO. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase. J Biol Chem. 2006;281:9971–6.CrossRefPubMed Taurin S, Sandbo N, Qin Y, Browning D, Dulin NO. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase. J Biol Chem. 2006;281:9971–6.CrossRefPubMed
35.
go back to reference van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H. Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem. 2002;277:17901–5.CrossRefPubMed van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H. Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem. 2002;277:17901–5.CrossRefPubMed
36.
go back to reference Wei A, Fan B, Zhao Y, Zhang H, Wang L, Yu X, et al. ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3beta/beta-catenin signaling pathway. Oncotarget. 2016;7:65374–88.PubMedPubMedCentral Wei A, Fan B, Zhao Y, Zhang H, Wang L, Yu X, et al. ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3beta/beta-catenin signaling pathway. Oncotarget. 2016;7:65374–88.PubMedPubMedCentral
37.
go back to reference Qian HY, Zhang DG, Wang HW, Pei DS, Zheng JN. Tyrosine phosphorylation of beta-catenin affects its subcellular localization and transcriptional activity of beta-catenin in Hela and Bcap-37 cells. Bioorg Med Chem Lett. 2014;24:2565–70.CrossRefPubMed Qian HY, Zhang DG, Wang HW, Pei DS, Zheng JN. Tyrosine phosphorylation of beta-catenin affects its subcellular localization and transcriptional activity of beta-catenin in Hela and Bcap-37 cells. Bioorg Med Chem Lett. 2014;24:2565–70.CrossRefPubMed
38.
go back to reference Choi CH, Lee BH, Ahn SG, Oh SH. Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3beta. Biochem Biophys Res Commun. 2012;418:759–64.CrossRefPubMed Choi CH, Lee BH, Ahn SG, Oh SH. Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3beta. Biochem Biophys Res Commun. 2012;418:759–64.CrossRefPubMed
39.
go back to reference Zhu Y, Xu L, Zhang J, Xu W, Liu Y, Yin H, et al. Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3beta/snail signaling in renal cell carcinoma. Cancer Sci. 2013;104:663–71.CrossRefPubMed Zhu Y, Xu L, Zhang J, Xu W, Liu Y, Yin H, et al. Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3beta/snail signaling in renal cell carcinoma. Cancer Sci. 2013;104:663–71.CrossRefPubMed
Metadata
Title
Stress-inducible Protein-1 promotes metastasis of gastric cancer via Wnt/β-catenin signaling pathway
Authors
Linlin Huang
Ertao Zhai
Shirong Cai
Yi Lin
Junbin Liao
Huilin Jin
Sui Peng
Lixia Xu
Minhu Chen
Zhirong Zeng
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2018
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/s13046-018-0676-8

Other articles of this Issue 1/2018

Journal of Experimental & Clinical Cancer Research 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine